Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen
- PMID: 9795103
- DOI: 10.1016/s0006-8993(98)00724-0
Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen
Abstract
DARPP-32, a dopamine and cAMP-regulated phosphoprotein with an apparent molecular weight of 32 kD, is enriched in dopaminoceptive brain regions. Chief among these regions is the caudatoputamen which contains a large number of DARPP-32-containing medium sized spiny neurons. Since medium spiny neurons are a heterogeneous population with respect to connections and chemical neuroanatomy, it seemed of interest to determine whether DARPP-32 is present in all medium-sized neurons, or only within a specific subpopulation. The present study used immunocytochemistry and quantitative analysis to address this issue. We demonstrate that DARPP-32 is contained in almost all medium-sized neurons (96.4%) and is not detected in large neurons. Taken together with previous observations that the DARPP-32-containing medium-sized neurons project heavily to all neostriatal targets, these data demonstrate that DARPP-32 is present in virtually all neostriatal output neurons. Thus, the DARPP-32 cascade represents a final common pathway through which convergent afferent fibers using a variety of neurotransmitter agents may modulate striatal outflow.
Copyright 1998 Elsevier Science B.V.
Similar articles
-
Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen.Neuroscience. 1997 Jun;78(4):977-83. doi: 10.1016/s0306-4522(96)00583-0. Neuroscience. 1997. PMID: 9174066
-
Distribution of DARPP-32 in the basal ganglia: an electron microscopic study.J Neurocytol. 1990 Feb;19(1):39-52. doi: 10.1007/BF01188438. J Neurocytol. 1990. PMID: 2191086
-
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.J Neurosci. 1984 Jan;4(1):111-24. doi: 10.1523/JNEUROSCI.04-01-00111.1984. J Neurosci. 1984. PMID: 6319625 Free PMC article.
-
DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.Parkinsonism Relat Disord. 2004 Jul;10(5):281-6. doi: 10.1016/j.parkreldis.2004.02.010. Parkinsonism Relat Disord. 2004. PMID: 15196506 Review.
-
DARPP-32 as a marker for D-1 dopaminoceptive cells in the rat brain: prenatal development and presence in glial elements (tanycytes) in the basal hypothalamus.Adv Exp Med Biol. 1988;235:65-82. doi: 10.1007/978-1-4899-2723-1_6. Adv Exp Med Biol. 1988. PMID: 2976255 Review.
Cited by
-
Mono- and Biallelic Inactivation of Huntingtin Gene in Patient-Specific Induced Pluripotent Stem Cells Reveal HTT Roles in Striatal Development and Neuronal Functions.J Huntingtons Dis. 2024;13(1):41-53. doi: 10.3233/JHD-231509. J Huntingtons Dis. 2024. PMID: 38427495 Free PMC article.
-
Altering Opioid Neuromodulation in the Songbird Basal Ganglia Modulates Vocalizations.Front Neurosci. 2019 Jul 3;13:671. doi: 10.3389/fnins.2019.00671. eCollection 2019. Front Neurosci. 2019. PMID: 31333400 Free PMC article.
-
Striatal signal transduction and drug addiction.Front Neuroanat. 2011 Sep 20;5:60. doi: 10.3389/fnana.2011.00060. eCollection 2011. Front Neuroanat. 2011. PMID: 21960960 Free PMC article.
-
A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.CNS Neurosci Ther. 2015 Aug;21(8):662-71. doi: 10.1111/cns.12425. Epub 2015 Jun 30. CNS Neurosci Ther. 2015. PMID: 26122704 Free PMC article.
-
Modeling Huntington's disease with induced pluripotent stem cells.Mol Cell Neurosci. 2013 Sep;56:50-64. doi: 10.1016/j.mcn.2013.02.005. Epub 2013 Feb 28. Mol Cell Neurosci. 2013. PMID: 23459227 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources